- CA$2.48bn
- CA$2.42bn
- $853.00m
- 58
- 43
- 63
- 55
2020 February 29th | 2021 February 28th | 2022 February 28th | 2023 February 28th | 2024 February 29th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,040 | 893 | 718 | 656 | 853 |
Cost of Revenue | |||||
Gross Profit | 768 | 643 | 467 | 419 | 520 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,189 | 2,000 | 720 | 1,381 | 978 |
Operating Profit | -149 | -1,107 | -2 | -725 | -125 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -148 | -1,113 | 19 | -720 | -106 |
Provision for Income Taxes | |||||
Net Income After Taxes | -152 | -1,104 | 12 | -734 | -130 |
Net Income Before Extraordinary Items | |||||
Net Income | -152 | -1,104 | 12 | -734 | -130 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -152 | -1,104 | 12 | -734 | -130 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.22 | -1.29 | -0.031 | -0.543 | -0.126 |